about
Bone marrow p16INK4a-deficiency does not modulate obesity, glucose homeostasis or atherosclerosis developmentPeroxisome proliferator-activated receptor-alpha gene level differently affects lipid metabolism and inflammation in apolipoprotein E2 knock-in miceDownregulation of the tumour suppressor p16INK4A contributes to the polarisation of human macrophages toward an adipose tissue macrophage (ATM)-like phenotypeLDL receptor knock-out mice are a physiological model particularly vulnerable to study the onset of inflammation in non-alcoholic fatty liver disease.Internalization of modified lipids by CD36 and SR-A leads to hepatic inflammation and lysosomal cholesterol storage in Kupffer cells.Role of scavenger receptor A and CD36 in diet-induced nonalcoholic steatohepatitis in hyperlipidemic mice.Understanding hyperlipidemia and atherosclerosis: lessons from genetically modified apoe and ldlr mice.Ablation of CD8α(+) dendritic cell mediated cross-presentation does not impact atherosclerosis in hyperlipidemic mice.p16INK4a deficiency promotes IL-4-induced polarization and inhibits proinflammatory signaling in macrophages.Methylglyoxal-Derived Advanced Glycation Endproducts in Multiple Sclerosis.Activation of intestinal peroxisome proliferator-activated receptor-α increases high-density lipoprotein production.A novel 72-kDa leukocyte-derived osteoglycin enhances the activation of toll-like receptor 4 and exacerbates cardiac inflammation during viral myocarditis.Roles of PPARs in NAFLD: potential therapeutic targets.Early diet-induced non-alcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibrates.Functional genomics of the CDKN2A/B locus in cardiovascular and metabolic disease: what have we learned from GWASs?Deficiency of the oxygen sensor prolyl hydroxylase 1 attenuates hypercholesterolaemia, atherosclerosis, and hyperglycaemia.Human adipose tissue macrophages display activation of cancer-related pathwaysMacrophage microRNA-155 promotes cardiac hypertrophy and failure.The tumour suppressor CDKN2A/p16INK4a regulates adipogenesis and bone marrow-dependent development of perivascular adipose tissue.Intrahepatic cholesterol influences progression, inhibition and reversal of non-alcoholic steatohepatitis in hyperlipidemic mice.Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis.Adipose tissue macrophages induce hepatic neutrophil recruitment and macrophage accumulation in mice.Cardiac Troponin T and I Release After a 30-km Run.Macrophage complexity in human atherosclerosis: opportunities for treatment?Advanced Glycation Endproducts Are Increased in the Animal Model of Multiple Sclerosis but Cannot Be Reduced by Pyridoxamine Treatment or Glyoxalase 1 Overexpression.Higher levels of advanced glycation endproducts in human carotid atherosclerotic plaques are associated with a rupture-prone phenotype.Parity-induced changes in global gene expression in the human mammary gland.Abdominal subcutaneous and visceral adipocyte size, lipolysis and inflammation relate to insulin resistance in male obese humans.RAGE deficiency does not affect non-alcoholic steatohepatitis and atherosclerosis in Western type diet-fed Ldlr miceMethylglyoxal-Derived Advanced Glycation Endproducts Accumulate in Multiple Sclerosis LesionsAnticoagulant effect of dietary fish oil in hyperlipidemia: a study of hepatic gene expression in APOE2 knock-in miceAdipose tissue macrophages do not affect atherosclerosis development in miceHepatic PPARα is critical in the metabolic adaptation to sepsisPlant-based sterols and stanols in health & disease: "Consequences of human development in a plant-based environment?"The endothelial function biomarker soluble E-selectin is associated with nonalcoholic fatty liver diseaseHepatic Fat Content and Liver Enzymes Are Associated with Circulating Free and Protein-Bound Advanced Glycation End Products, Which Are Associated with Low-Grade Inflammation: The CODAM Study
P50
Q28731544-ECE55D41-118F-4F9A-ACF7-D3C6B3189772Q30513404-B7D396AA-65EF-40F4-95D1-264B6F475FDBQ33610073-AABB2C52-F8ED-4D3D-8C17-80FBEA36BE79Q34147643-875D4645-A82D-45C1-845A-67F4FC697EA7Q34217939-4A7816ED-1D58-413D-A446-F233FC5020D2Q35044164-491F6780-11C2-4377-97BE-9A02A4D30B07Q36130584-9A29DBAD-967C-49FE-B3C4-BAD1865F1A80Q36186394-CA2B8FB4-3909-4492-A29C-6D6F7A2B5A62Q36916423-B2D2CC37-76EA-4F9C-86E0-DA85E1CC0A2DQ37690997-A05495DC-7A3F-449C-8044-0D5D8F2398BCQ37699483-101841E5-6248-4F81-AB1C-3F5324091569Q37709993-79F26D70-136D-4102-AB25-C94954866EE0Q37953148-005CF444-378B-4546-A96E-ED893CF1F795Q38316076-DF5E8611-DF8A-4428-9FF2-C4AD5DAD64D4Q38368484-4A32288F-3DE8-482E-A3E2-274DE2AB067DQ38874372-EA9C427C-5647-48B6-AA49-68D0393332C0Q39362988-32F8557F-2333-4EF9-AC92-57CB55DB08EAQ42250729-E02D38CA-018C-4D3C-BD38-DFD9EC9DBAEBQ42649980-2B4F38A3-B66F-4223-9A37-6BB4DEFC3D10Q43180173-7320B151-BF38-41C7-8F48-69A3F43DFCB0Q46455735-60EE4798-2179-472E-B72B-8A3D7C2992C1Q47598043-E618411E-10EC-46BD-9097-91E747F9418FQ48685870-780EB810-FC95-4C80-93BA-ADFEB7B55BFEQ52558693-ABD6CA1F-8518-4060-90C9-9720EE5B6806Q52716248-B0F75A50-64D6-4D41-8CC9-44BE314A9AB0Q53786578-8EFB46E7-B183-422F-8897-A9A59DB15F4CQ54674458-55E54E54-573F-48F3-A632-D4D94F1DE7DFQ55030703-7C370126-654B-4BE8-B69C-E9C5612850D3Q57466113-2E8B5A73-E88F-4B4A-93FE-A73BD8BBE2A6Q64093260-A1238077-14FA-4C0D-A0CE-8A190DEFE6E8Q81895365-FD2200C5-8FFF-4261-AF0F-9802451C63CAQ91092143-E459A2CB-7423-46D3-8C70-2568147A754BQ91199192-6BB64794-B2A4-456A-95E7-DEF0FAB828F7Q92044299-82366A21-B112-40E3-B683-2F51343B2B53Q92791721-750D8E0D-3B9F-4318-A81F-D863E4293FC7Q92889825-1107E44B-4080-4CB0-ADB6-2D2101D0BF59
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Kristiaan Wouters
@ast
Kristiaan Wouters
@en
Kristiaan Wouters
@es
Kristiaan Wouters
@nl
type
label
Kristiaan Wouters
@ast
Kristiaan Wouters
@en
Kristiaan Wouters
@es
Kristiaan Wouters
@nl
prefLabel
Kristiaan Wouters
@ast
Kristiaan Wouters
@en
Kristiaan Wouters
@es
Kristiaan Wouters
@nl
P106
P31
P496
0000-0001-7127-6950